Company
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
67 Case(s) (Last 5 Years)
Patents Prosecuted
| Application number | Title of the patent | IPC | Filing Date | Decision Date |
|---|---|---|---|---|
| 17226233 | METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | A61K, G01N, A61P | Apr 8, 2021 | |
| 17995848 | CRYSTALLINE FORMS OF (9R, 135S)-13- {4-[5-CHLORO-2-(4-CHLORO-1H,2,3- TRIAZOL- 1 -YL)PHENYL] -6-OXO- 1,6-DIHYDROPYRIMIDIN- 1-YL}-3-(DIFLUOROMETHYL)-9-METHYL-3,4,7,15- TETRAAZATRICYCLO [ 12.3.1.0 2*6] OCTADECA- 1(18), 2(6), 4, 14, 16-PENTAEN-8-ONE | C07D | Apr 8, 2021 | |
| 17221107 | MONITORING AND COMMUNICATING INFORMATION USING DRUG ADMINISTRATION DEVICES | A61B, G16H, A61M, H04W | Apr 1, 2021 | |
| 17212274 | Aryl piperidines as monoacylglycerol lipase modulators | C07D | Mar 24, 2021 | Oct 16, 2023 |
| 17212338 | Azaspirocycles as monoacylglycerol lipase modulators | C07D | Mar 24, 2021 | Nov 21, 2022 |
| 17212377 | Monoacylglycerol lipase modulators | C07D | Mar 24, 2021 | Feb 5, 2024 |
| 17212302 | Aminocyclobutanes as monoacylglycerol lipase modulators | C07D | Mar 24, 2021 | Nov 28, 2022 |
| 17191870 | COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTION | A61K, A61P, C12N | Mar 3, 2021 | |
| 17904412 | MACROCYCLIC INDOLE DERIVATIVES AS INHIBITORS OF MCL-1 | C07D, A61P | Feb 17, 2021 | |
| 17904139 | FGFR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER | A61P, A61K | Feb 10, 2021 | |
| 17171559 | Monoacylglycerol lipase modulators | C07D | Feb 8, 2021 | Jul 24, 2023 |
| 17168325 | Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors | A61P, C07K, A61K | Feb 4, 2021 | Aug 21, 2023 |
| 17168503 | Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors | A61P, C07K, A61K | Feb 4, 2021 | Sep 25, 2023 |
| 17167595 | MDR | C07K, A61K, G01N | Feb 3, 2021 | Dec 19, 2022 |
| 17163357 | Compositions and methods for preventing and treating coronavirus infection--SARS-CoV-2 vaccines | C07K, A61P, A61K, C12N | Jan 29, 2021 | Nov 14, 2022 |
| 17150025 | FimH mutant, compositions therewith and use thereof | A61K, C07K | Jan 14, 2021 | Aug 22, 2022 |
| 17149703 | System and method for healthcare security and interoperability | H04L, G16H | Jan 13, 2021 | Dec 26, 2022 |
| 17149707 | System and method for healthcare security and interoperability | G16H | Jan 13, 2021 | Dec 19, 2022 |
| 17127569 | Inhibitors of KEAP1-Nrf2 protein-protein interaction | C07D | Dec 17, 2020 | Feb 12, 2024 |
| 17757637 | OGA INHIBITOR COMPOUNDS | C07D | Dec 17, 2020 |